Angiocrine Bioscience, Inc.

Angiocrine Bioscience is a private, clinical stage engineered cell therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function and rejuvenate patients with serious medical conditions. Our team is developing a pipeline of proprietary engineered endothelial cell (E-CEL? ) therapies for treating multiple life-threatening hemato-oncologic and immunologic conditions, as well as, regenerating tissues and organs that have been injured or damaged by diseases.

网站

https://www.angiocrinebioscience.com

Angiocrine Bioscience, Inc.的外部链接

所属行业

生物技术

规模

11-50 人

总部

San Diego，California

类型

私人持股

创立

2012

领域

Proprietary genetically engineered cellular E-CEL? Technology Platform, with potential applications in cellular immunotherapy for hematologic cancers, cellular regenerative medicine, and hematopoietic stem cell gene therapy.